219 related articles for article (PubMed ID: 11306831)
1. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis.
Okano M
Dermatology; 2001; 202(2):116-8. PubMed ID: 11306831
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical calcipotriol on congenital ichthyoses.
Lucker GP; van de Kerkhof PC; van Dïjk MR; Steijlen PM
Br J Dermatol; 1994 Oct; 131(4):546-50. PubMed ID: 7947208
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients.
Prignano F; Buggiani G; Lotti T
Acta Biomed; 2009 Apr; 80(1):51-6. PubMed ID: 19705621
[TBL] [Abstract][Full Text] [Related]
5. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
7. Topical tacalcitol treatment for psoriasis.
Harrison PV
Hosp Med; 2000 Jun; 61(6):402-5. PubMed ID: 10962655
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
Ruzicka T; Trompke C
Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nevoid hyperkeratosis of the areola and nipple with topical tacalcitol: A case report.
Cinotti E; Provvidenziale L; Miracco C; Rubegni P
Dermatol Ther; 2018 Jul; 31(4):e12602. PubMed ID: 29624812
[No Abstract] [Full Text] [Related]
10. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
11. 1 alpha,25-(OH)2D3 use on psoriasis and ichthyosis.
Okano M
Int J Dermatol; 1991 Jan; 30(1):62-4. PubMed ID: 1993570
[TBL] [Abstract][Full Text] [Related]
12. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
Nakayama J
Eur J Dermatol; 2000; 10(7):528-32. PubMed ID: 11056423
[TBL] [Abstract][Full Text] [Related]
13. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
Thiers BH
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
15. Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment.
Lucker GP; Steijen PM; Suykerbuyk EJ; Kragballe K; Brandrup F; van de Kerkhof PC
Acta Derm Venereol; 1996 Mar; 76(2):97-101. PubMed ID: 8740259
[TBL] [Abstract][Full Text] [Related]
16. A case of subcorneal pustular dermatosis treated with tacalcitol (1alpha,24-dihydroxyvitamin D3).
Kawaguchi M; Mitsuhashi Y; Kondo S
J Dermatol; 2000 Oct; 27(10):669-72. PubMed ID: 11092273
[TBL] [Abstract][Full Text] [Related]
17. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
[TBL] [Abstract][Full Text] [Related]
18. First case report of topical tacalcitol for vitiligo repigmentation.
Amano H; Abe M; Ishikawa O
Pediatr Dermatol; 2008; 25(2):262-4. PubMed ID: 18429797
[TBL] [Abstract][Full Text] [Related]
19. Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury.
Mommers JM; ter Meulen AC; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1999; 12(4):174-81. PubMed ID: 10420137
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream.
Tadini G; Giustini S; Milani M
Curr Med Res Opin; 2011 Dec; 27(12):2279-84. PubMed ID: 22007909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
